Los Angeles Capital Management LLC Sells 1,652 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Los Angeles Capital Management LLC lowered its position in Option Care Health, Inc. (NASDAQ:OPCHFree Report) by 18.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,511 shares of the company’s stock after selling 1,652 shares during the period. Los Angeles Capital Management LLC’s holdings in Option Care Health were worth $208,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. increased its holdings in shares of Option Care Health by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 19,626,205 shares of the company’s stock valued at $661,207,000 after purchasing an additional 306,853 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Option Care Health by 157.1% in the fourth quarter. Wellington Management Group LLP now owns 7,445,556 shares of the company’s stock valued at $250,841,000 after purchasing an additional 4,549,164 shares in the last quarter. Westfield Capital Management Co. LP increased its holdings in shares of Option Care Health by 15.4% in the first quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock valued at $173,448,000 after purchasing an additional 688,653 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Option Care Health by 8.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,191,672 shares of the company’s stock worth $107,530,000 after acquiring an additional 258,933 shares during the period. Finally, Norges Bank acquired a new position in shares of Option Care Health in the 4th quarter valued at $64,343,000. Institutional investors own 98.05% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on OPCH shares. Barrington Research boosted their price target on shares of Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a report on Thursday, August 1st. JMP Securities started coverage on shares of Option Care Health in a research report on Tuesday, July 16th. They set an “outperform” rating and a $36.00 price target on the stock.

View Our Latest Report on OPCH

Option Care Health Stock Up 0.6 %

Shares of OPCH stock opened at $31.99 on Monday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.36 and a current ratio of 1.76. The firm’s 50-day moving average is $30.84 and its 200-day moving average is $30.48. The stock has a market cap of $5.56 billion, a price-to-earnings ratio of 21.05, a PEG ratio of 2.46 and a beta of 1.29. Option Care Health, Inc. has a 52-week low of $26.11 and a 52-week high of $35.24.

Option Care Health (NASDAQ:OPCHGet Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.03. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The business had revenue of $1.23 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same quarter in the prior year, the business earned $0.63 EPS. Option Care Health’s quarterly revenue was up 14.8% on a year-over-year basis. Sell-side analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Activity at Option Care Health

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The disclosure for this sale can be found here. 0.64% of the stock is owned by company insiders.

Option Care Health Company Profile

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Featured Articles

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCHFree Report).

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.